Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 22,271 | 25,178 | 2,552 | 245 |
| Gross Profit | N/A | 22,271 | 25,178 | 2,552 | 245 |
| Operating Expenses | 108,142 | 64,834 | 49,256 | 32,249 | 21,183 |
| Operating Income | -108,142 | -42,563 | -24,078 | -29,697 | -20,938 |
| Interest Expense | 3,046 | 0 | 0 | 0 | 0 |
| Other Income | 6,146 | 2,098 | 1,790 | 678 | 916 |
| Pre-tax Income | -105,042 | -40,466 | -22,288 | -29,020 | -20,023 |
| Income Tax | 2 | 2 | N/A | N/A | N/A |
| Net Income Continuous | -105,044 | -40,467 | -22,288 | -29,020 | -20,023 |
| Net Income | $-105,044 | $-40,467 | $-22,288 | $-29,020 | $-20,023 |
| EPS Basic Total Ops | -2.26 | -1.15 | -0.83 | -1.18 | -0.87 |
| EPS Basic Continuous Ops | -2.26 | -1.15 | -0.83 | -1.18 | -0.87 |
| EPS Diluted Total Ops | -2.26 | -1.15 | -0.83 | -1.18 | -0.87 |
| EPS Diluted Continuous Ops | -2.26 | -1.15 | -0.83 | -1.18 | -0.87 |
| EPS Diluted Before Non-Recurring Items | -2.26 | -1.15 | -0.83 | -1.18 | -0.87 |
| EBITDA(a) | $-106,253 | $-41,138 | $-23,009 | $-29,164 | $-20,693 |